dc.contributor.author | Yilmaz, Akar | |
dc.contributor.author | Unlucerci, Yesim | |
dc.contributor.author | Develi, Seval | |
dc.contributor.author | Bekpinar, Seldağ | |
dc.contributor.author | Gurdol, Figen | |
dc.date.accessioned | 2021-03-05T10:09:24Z | |
dc.date.available | 2021-03-05T10:09:24Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | Bekpinar S., Gurdol F., Unlucerci Y., Develi S., Yilmaz A., "Serum levels of arginase I are associated with left ventricular function after myocardial infarction", CLINICAL BIOCHEMISTRY, cilt.44, ss.1090-1093, 2011 | |
dc.identifier.issn | 0009-9120 | |
dc.identifier.other | av_a19ae0f1-5d1b-45f1-bc37-15fc70347fa7 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/108276 | |
dc.identifier.uri | https://doi.org/10.1016/j.clinbiochem.2011.06.003 | |
dc.description.abstract | Objectives: Upregulation of arginase redirects the arginine metabolism from nitric oxide (NO) synthesis to the formation of polyamine and proline, thus causing cardiac dysfunction. NO synthesis is also impaired by asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor. We aimed to evaluate the impact of arginase and ADMA levels on left ventricular function after myocardial infarction (MI). | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | TIBBİ LABORATUVAR TEKNOLOJİSİ | |
dc.subject | Klinik Tıp | |
dc.subject | Tıp | |
dc.title | Serum levels of arginase I are associated with left ventricular function after myocardial infarction | |
dc.type | Makale | |
dc.relation.journal | CLINICAL BIOCHEMISTRY | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 44 | |
dc.identifier.issue | 13 | |
dc.identifier.startpage | 1090 | |
dc.identifier.endpage | 1093 | |
dc.contributor.firstauthorID | 29734 | |